Almost 30 years after it was first licensed as a treatment for breast cancer, aromatase inhibitor anastrozole has been cleared for preventive use in women at high risk of developing the disease in ...

The American investment company GTCR LLC is negotiating with creditors to raise financing as part of the proposed acquisition of Zentiva, a generic drug manufacturer controlled by Advent International ...

AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs. The new investment will grow its workforce at the site to ...